Literature DB >> 25935517

Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.

Min Jung Park1, Kristen N Ganjoo2, Amy L Ladd3.   

Abstract

Juxta-articular giant cell tumors can pose major surgical challenges. Aggressive distal radius giant cell tumors often require complex reconstructive procedures that are associated with numerous complications. We present a case of a 25-year old man with a Campanacci grade 3 giant cell tumor of the distal radius that was successfully treated with denosumab without complex reconstructive procedures. At 3.5-year follow-up and 1-year drug free period, the patient remained asymptomatic without histologic evidence of recurrent tumor. With denosumab therapy, patients can potentially avoid surgery and achieve a successful outcome.
Copyright © 2015 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Denosumab; distal radius; giant cell tumor

Mesh:

Substances:

Year:  2015        PMID: 25935517     DOI: 10.1016/j.jhsa.2015.03.018

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  CORR Insights®: What are the Functional Results, Complications, and Outcomes of Using a Custom Unipolar Wrist Hemiarthroplasty for Treatment of Grade III Giant Cell Tumors of the Distal Radius?

Authors:  Howard A Chansky
Journal:  Clin Orthop Relat Res       Date:  2016-09-13       Impact factor: 4.176

Review 2.  Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence.

Authors:  Aneta Maria Borkowska; Anna Szumera-Ciećkiewicz; Bartłomiej Szostakowski; Andrzej Pieńkowski; Piotr Lukasz Rutkowski
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

3.  Giant cell tumour of the distal radius/ulna: response to pre-operative treatment with short-term denosumab.

Authors:  Catherine L McCarthy; Christopher L M H Gibbons; Kevin M Bradley; A Bass Hassan; Henk Giele; Nicholas A Athanasou
Journal:  Clin Sarcoma Res       Date:  2017-11-30

4.  Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.

Authors:  Josef Yayan
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.